Skip to main content

News All News

Press Contact: Kirsten Mabry | (617) 495-4157

Tag: Startups

October 2nd, 2024

Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies

Attivare Therapeutics, a Harvard startup out of the Wyss Institute, has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute, and Massachusetts General Hospital. This technology creates an in vivo training ground for the immune system to fight cancer more effectively and prevent infection.

September 10th, 2024

Harvard Grid names inaugural fellows

Harvard Grid will support two postdoctoral fellows at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) in a year-long translation immersion program in its inaugural Grid Fellowship cohort.

Page 1 of 15